Celularity Inc (CELU): Nasdaq/NYSE listing notice — Celularity receives Nasdaq delisting notice for late 10-K filing; must submit plan by June 17

Celularity Inc

Failed to file 2023 Form 10-K by April 15 extension; Nasdaq notified on April 17, 2024.
Common stock (CELU) and warrants (CELUW) continue trading; no immediate delisting.
Must submit compliance plan within 60 days (by June 17, 2024); if accepted, cure by Oct 14, 2024.
No assurance of regaining compliance; delisting possible if plan not accepted or cure fails.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Celularity Inc received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

April 17, 2024, Celularity informed the Listing Qualifications department of the Nasdaq Stock Market LLC, or Nasdaq, that it failed to timely file its 2023 Form 10-K within the extension period provided by Rule 12b-25 because Celularity had not yet completed the preparation of the financial statements for the year ended December 31, 2023. On April 17, 2024, Nasdaq provided formal notice to Celularity that as a result of Celularity’s failure to timely file its 2023 Form 10-K, it no longer complied with the continued listing requirements under the timely filing criteria outlined in Nasdaq Listin

View on SEC.gov

Browse all listing & compliance notices →

Celularity Inc filing history →

Source: SEC EDGAR

accession 0001493152-24-015455

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.